Our goal at Good News IVF is to offer the most cutting-edge fertility care tests and treatments available. This enables us to evaluate and enhance reproductive outcomes as effectively as possible using these cutting-edge methods. Some of our state-of-the-art services are listed below:
A genetic test called PGT-A can identify chromosomal abnormalities in embryos. Better selection of the healthiest embryos for transfer lowers the incidence of miscarriage and increases the likelihood of becoming pregnant.
PRP therapy is a regenerative treatment that can help improve endometrial thickness and ovarian function, particularly in women with poor ovarian response or thin uterine linings. It raises the chances of implantation and, ultimately, pregnancy.
In order to accurately match the timing of embryo transfer to implantation, the ERA test is used to assess the uterine lining's receptivity. The likelihood that IVF cycles will be successful is increased by this test.
Regardless of the sperm's motility, the Hypo Osmotic Swelling (HOS) test evaluates the sperm's viability and function to ascertain whether they can fertilize an egg.
It does, however, gauge the sperm DNA's integrity. In addition to lowering reproductive potential, this diagnostic test looks for significant amounts of DNA fragmentation, which are not picked up by routine semen analysis.
An improved version of ICSI called IMSI selects sperm from extremely high magnification images to improve fertilization and even embryo development.